DWTX
$3.22
Pre-MarketAs of Mar 17, 8:00 PM UTC
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
Recent News
Dogwood Therapeutics Says Interim Phase 2B Data Show Pain Improvement With Halneuron
Dogwood Therapeutics (DWTX) said Monday that an interim analysis of its Phase 2b study for Halneuron
Potential Government Shutdown in Focus as US Equity Futures Rise Pre-Bell
US equity futures were higher pre-bell Monday as traders appeared to brush off concerns over a poten